A three-drug regimen involving a PD-L1 inhibitor and two targeted agents was active and safe for treating the diffuse large B-cell lymphoma (DLBCL) variant of Richter transformation, the phase II ...
SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback